Grigorian-Shamagian, Lilian
Coca, Antonio
Morais, Joao
Perez-Martinez, Pablo
,
Barragan, Adriana
Barrientos, Ana Isabel
e Silva, Alexandre Amaral
Sugraliyev, Akhmetzhan
Parkhomenko, Alexander
Liprandi, Álvaro Sosa
Parapid, Biljana
Olivares, Carlos
Negretti, Carlos Ignacio Ponte
Quesada, Daniel
Kosevic, Dragana
Gastelum, Edith Ruiz
López, Emilio Samael Peralta
Araujo, Francisco
Padilla Padilla, Francisco Gerardo
Krzesinski, François
Alhaddad, Imad
Fernandez, Jose Alejandro Chavez
Gonzalez-Juanatey, Jose R.
Arnaout, M. Samir
Castellanos, Mar
Mendez, Maxima
Acevedo, Monica
Koval, Olena
Jorge, Pablo
Zelveian, Parounak
Kreutz, Reinhold
Tseluyko, Vira
Article History
Accepted: 14 July 2023
First Online: 17 August 2023
Change Date: 12 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12919-023-00279-6
Declarations
:
: Not applicable.
: Not applicable.
: LG-S has no competing interests to declare. AC has received honoraria for lectures in symposia and educational activities sponsored by unrestricted grants from Abbott, Berlin-Chemie, Biolab, Boehringer, Ferrer, Menarini, Merck, and Sanofi. JM has received honoraria for lectures in symposia and educational activities sponsored by unrestricted grants from, Astra Zeneca, Bayer, Novartis, Menarini, and Servier. PP-M has received fees for lectures and educational activities from Novo-Nordisk, Boehringer Ingelheim, Amgen, Laboratorios Dr Esteve, MSD, Ferrer, Menarini, Servier, and Viatrix.